← Eichor
Condition: Remission Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Remission

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06245746
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06232694
Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
Phase 4 · 7 location(s) · Oslo University Hospital · NCT06653634
MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia
NA · 1 location(s) · King Hussein Cancer Center · NCT07371403
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880
Discontinuation Study
NA · 1 location(s) · University College Cork · NCT05866757
Pathway to Peanut Tolerance
NA · 1 location(s) · Chinese University of Hong Kong · NCT07592780
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cel
Phase 3 · 2 location(s) · Shandong Cancer Hospital and Institute · NCT04829708
AIRE-2 Device for Study of Breath Analysis in IBD
NA · 1 location(s) · McMaster University · NCT06541938
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Phase N/A · 38 location(s) · Pfizer · NCT06294925
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed
Phase 2 · 6 location(s) · Academic and Community Cancer Research United · NCT06238648
Remission Factors in Anorexia Nervosa
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04560517
Rheumatoid Arthritis Remission Screening and Prospective Surveillance
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07571993
Remission in Adults With Severe Asthma in Thailand
Phase N/A · 1 location(s) · Thammasat University · NCT07328035
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07101588
Surgery Versus Best Medical Management for the Long Term Remission of Type 2 Diabetes and Related Diseases (REMISSION)
NA · 1 location(s) · Laval University · NCT02390973
Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06034561
Combination of Diet and Oral Budesonide for Ulcerative Colitis
NA · 6 location(s) · Wolfson Medical Center · NCT05791487
Remission of Diabetes With Lifestyle Intervention for Malaysian Patients
NA · 2 location(s) · Winnie Chee Siew Swee · NCT07270068
A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia
Phase 2 · 1 location(s) · Korean Society of Hematology · NCT06368414
Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05909293
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
Phase 4 · 1 location(s) · Institutul Clinic Fundeni · NCT05207358
Biomarker Development for Autoimmune Disorders Involving the Kidneys
Phase N/A · 1 location(s) · Oslo University Hospital · NCT07666711
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Phase 3 · 5 location(s) · Université de Sherbrooke · NCT07309614
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Phase N/A · 1 location(s) · Université Catholique de Louvain · NCT07000916
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06718244
Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3 · 1 location(s) · Amsterdam University Medical Center (UMC), Location Academic · NCT06714838
Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy
NA · 9 location(s) · Francisco J. Blanco · NCT07678112
Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT05439889
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
Phase 1 · 1 location(s) · Henry M. Jackson Foundation for the Advancement of Military · NCT06484335
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.